Get started
Author

Svetlana B. Artemyeva

Observed names: S. Artemyeva, S. B. Artemyeva, S. V. Artemyeva, S. В. Artemyeva, S.B. Artemyeva, Svetlana Artemyeva, Артемьева Светлана Брониславовна
ORCID: 0000-0002-8876-7462
Observed ORCID: 0000-0002-8876-7462
OpenAlex ID: A5032012137
Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial
2022 · Riccardo Masson, Maria Mazurkiewicz-Bełdzińska, et al. · The Lancet Neurology · 117
PDF
Experience of using gene replacement therapy with Zolgensma® (onasemnogene abeparvovec) in real clinical practice in Russia
2022 · S. B. Artemyeva, Yu. O. Papina, et al. · Neuromuscular Diseases · 14
PDF
Duchenne Muscular Dystrophy: Modern Approaches in Patient Management
2023 · Inga V. Anisimova, Svetlana B. Artemyeva, et al. · Педиатрическая фармакология · 4
PDF
Consensus concept of modern effective therapy for Duchenne muscular dystrophy
2023 · T. A. Gremyakova, S. B. Artemyeva, et al. · Neuromuscular Diseases · 4
PDF
The concept of “ambulatory” and “non-ambulatory” in patients with Duchenne muscular dystrophy: definitions and criteria
2022 · T. A. Gremyakova, S. V. Artemyeva, et al. · Neuromuscular Diseases · 4
PDF
Consensus on gene replacement therapy for spinal muscular atrophy
2021 · S. B. Artemyeva, E. D. Belousova, et al. · L O Badalyan Neurological Journal · 4
Functional class criteria identification in patients with spinal muscular atrophy 5q
2025 · Yu. O. Papina, E. A. Melnik, et al. · Neuromuscular Diseases · 3
PDF
Assessment of social emotional, cognitive and communicative development and adaptive behavior in children with spinal muscular atrophy 5q
2025 · Yu. O. Papina, N. N. Zavadenko, et al. · Neuromuscular Diseases · 1
PDF
Administration of gene replacement therapy in patients with spinal muscular atrophy 5q type 1 with chronic nosocomial bronchopulmonary infection
2024 · Yuliya O. Papina, Svetlana B. Artemyeva, et al. · L O Badalyan Neurological Journal · 1
Approaches to pathogenetic therapy of spinal muscular atrophy in children and newborns
2024 · S. B. Artemyeva, O. A. Shidlovskaya, et al. · Neuromuscular Diseases · 1
PDF
Modern methods of therapy of Duchenne muscular dystrophy: literature review with a clinical case
2024 · S. B. Artemyeva, О. А. Shidlovskaya, et al. · Neuromuscular Diseases · 1
PDF
A clinical case of severe aromatic L-amino acid decarboxylase deficiency
2024 · O. A. Shidlovskaya, S. B. Artemyeva, et al. · Neuromuscular Diseases · 1
PDF
Registries and Care of Neuromuscular Disorders
2018 · S. Artemyeva, D. Vlodavets, et al. · Neuromuscular Disorders · 1
2.07P Preventing early mortality in COL6-RD: motor trajectories and proactive respiratory monitoring in a national cohort (n=190)
2026 · Diana Abramova, Svetlana Artemyeva, et al. · Neuromuscular Disorders
2.54eP Safety and efficacy of viltolarsen in DMD therapy. Data from 4 years of real clinical practice in Russia
2026 · Natalia Balamut, Dmitry Vlodavets, et al. · Neuromuscular Disorders
Clinical experience of treating 28 patients with Duchenne muscular dystrophy with the exon 45 skipping drug casimersen
2026 · A. A. Agafonova, S. B. Artemyeva, et al. · Neuromuscular Diseases
PDF
The role of rehabilitation in the development of motor skills in patients with spinal muscular atrophy 5q receiving pathogenetic therapy
2026 · Yuliya O. Papina, Aleksandr R. Stevanovich, et al. · L O Badalyan Neurological Journal
Pathogenetic therapy for Duchenne muscular dystrophy: Russian experience with viltolarsen
2026 · D. V. Vlodavets, S. B. Artemyeva, et al. · Russian Journal of Child Neurology
120PData trends and highlights from the Russian COL-6 patients registry
2025 · D. Abramova, S. Artemyeva, et al. · Neuromuscular Disorders
Consensus on implementation features of the Russian-manufactured generic Nusinersen (TN Lantesens) for SMA 5q treatment in Russia
2025 · Dina V. Ayzatulina, Svetlana B. Artemyeva, et al. · L O Badalyan Neurological Journal
PDF
Vamorolone – a corticosteroid approved by global regulators for the treatment of Duchenne muscular dystrophy. Literature review
2025 · D. V. Vlodavets, S. B. Artemyeva, et al. · Russian Journal of Child Neurology
PDF
Late diagnosis of spinal muscular atrophy, primary symptoms of the disease according to the patient registry of the SMA Families Foundation
2025 · S. В. Artemyeva, Yu. О. Papina, et al. · Meditsinskiy sovet = Medical Council
PDF
Проблемы смены терапии у пациентов с 5q-ассоциированной спинальной мышечной атрофией: обзор литературы и предложения экспертов
2025 · Иллариошкин Сергей Николаевич, Клюшников Сергей Анатольевич, et al. · CyberLeninK (CyberLeninka)
Manifestations of clinical polymorphism of myotonic dystrophy type 1: the two familial cases
2024 · E.K. Erokhina, E.A. Melnik, et al. · PEDIATRIA Journal named after G N SPERANSKY
Guidelines for Practitioners: Duchenne Muscular Dystrophy (DMD). Becker Muscular Dystrophy (BMD). Early diagnosis. Therapy with the use of drugs that are currently not registered properly in Russia/by the Ministry of Healthcare of Russia
2023 · T.A. Gremyakova, I.V. Anisimova, et al. · PEDIATRIA Journal named after G N SPERANSKY
Works count: 34
Citation count: 156
H-index: 4
I10-index: 2
Year
Topic
Type